Channel profile image
Featured Speakers
Sara Haddad's photo
Sara Haddad
Anthony Kerbage's photo
Anthony Kerbage
Daniel Ahn's photo
Daniel Ahn
Shivangini Duggal's photo
Shivangini Duggal
Talks (180)
Adjuvant therapy in BTC?
Jul 12
What’s Next?
Jul 07
Limitations and Learning
Jul 07
Observer Agreement
Jul 07
ME-OE: Better Accuracy, Sensitivity
Jul 07
Higher Yields with ME-OE
Jul 07
The Trial Design
Jul 07
Introducing ME-OE
Jul 07
White-Light Endoscopy: A Limitation?
Jul 07
The Correa Cascade
Jul 07
Why Gastric Cancer Detection Matters
Jul 07
Clinical Implications
Jul 07
Curative Conversion Therapy
Jul 07
Management of Recurrence
Jul 07
Duration of Therapy Beyond CR
Jul 07
The Validity of mRECIST in Immunotherapy
Jul 07
Survival Outcomes Following CR
Jul 07
Defining Response – RECIST vs. mRECIST
Jul 07
Patient Characteristics
Jul 07
Patient Characteristics
Jul 07
HCC and ICI therapy
Jul 07
FORTITUDE 101 positive
Jun 30
DESTINY GASTRIC -04 positive
Jun 26
TTFs in treatment of PDAC?
Jun 23
BESPOKE CRC_5
Jun 21
BESPOKE CRC_4
Jun 21
BESPOKE CRC_3
Jun 21
BESPOKE CRC_2
Jun 21
BESPOKE CRC_1
Jun 21
Breakwater trial_5
Jun 21
Breakwater trial_4
Jun 21
Breakwater trial_3
Jun 21
Breakwater trial_2
Jun 21
Breakwater trial_1
Jun 21
CRCExercise_10
Jun 19
CRCExercise_9
Jun 19
CRCExercise_8
Jun 19
CRCExercise_7
Jun 19
CRCExercise_6
Jun 19
CRCExercise_5
Jun 19
CRCExercise_4
Jun 19
CRCExercise_3
Jun 19
CRCExercise_2
Jun 19
CRCExercise_1
Jun 19
PIK3CA mutation testing in CRC
Jun 14
Research gaps
Jun 07
Algorithm for guiding therapy
Jun 07
Efficacy of Systemic Therapy in CPB (HCC
Jun 07
Side effects of Systemic Therapy
Jun 07
Portal HTN management in HCC
Jun 07
Antiviral Therapy in HCC
Jun 07
Antiviral Therapy in HCC
Jun 07
Hepatic Dysfunction in HCC
Jun 07
ALBI score
Jun 07
HCC Treatment in Advanced Liver disease
Jun 07
ATOMIC trial (2/2)
Jun 05
ATOMIC trial positive (1/2)
Jun 05
MATTERHORN trial resulted
Jun 01
OS results from BREAKWATER
May 30
ctDNA_GC_10
May 29
Loading logo